Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Alpelisib(Piqray)

Alpelisib combined with Fluvastatin in the treatment of postmenopausal women and men with breast cancer.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：200
Balversa(Erdafitinib)

Balversa is suitable for treating adult patients with locally advanced or metastatic urothelial carcinoma.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：248
Stiripentol(Diacomit)

Stiripentol is suitable for treating epileptic seizures associated with Dravet syndrome (DS).【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：244
Fidaxomicin(Dificid)

Used for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults and children aged 6 months and older.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：232
Ponatinib(Iclusig)

Chronic Myeloid Leukemia‌ and Acute Lymphoblastic Leukemia‌.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：183
Lenvatinib(Lenvima)

Lenvatinib is indicated for differentiated thyroid carcinoma (DTC), renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and endometrial carcinoma (EC).【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：60
Tucatinib(Tukysa)

Tucatinib can be used to treat breast cancer and colorectal cancer in adult patients.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：175
Vigabatrin(Sabril)

Vigabatrin is an adjuvant therapy for refractory complex partial epilepsy patients aged 2 years and above.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：148
Entrectinib(Rozlytrek)

Entrectinib is a Broad-spectrum antitumor agents.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：71
Upadacitinib(Rinvoq)

Upadacitinib can regulate abnormal immune responses, alleviate inflammation and symptoms of diseases.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：116
Tivozanib(Fotivda)

Recurrent or refractory advanced renal cell carcinoma (RCC) after two or more previous systemic treatments.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：158
Repotrectinib(Augtyro)

Adult patients with locally advanced or metastatic ROS1 positive non-small cell lung cancer (NSCLC).【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：194

home page previous 44 44/102 next last page

News

The U.S. FDA approved the combination of Pembrolizumab and Enfortumab vedotin-ejfv for the treatment
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】

Recommended：[list:visits]2025-17-12
Lucius Pharmaceuticals Laos launched lorlatinib, a third-generation targeted drug for lung cancer
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】

Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】

Recommended：[list:visits]2026-06-08
Lao Pharmacies and Manufacturer Direct Shipping: Legal Pathways and Pitfall Guide for Overseas Medi
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】

Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】

Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now available
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】

Recommended：[list:visits]2026-03-08
Laos Lucius, ASEAN Pharmaceuticals (TLPH), and Alliance Pharmaceuticals: Which generic drug manufac
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】

Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in Laos
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】

Recommended：[list:visits]2026-30-07

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More